lncRNA-MEG3 Suppresses the Proliferation and Invasion of Melanoma by Regulating CYLD Expression Mediated by Sponging miR-499-5p

MiR-767 promoted cell proliferation in human melanoma by suppressing CYLD expression

(2018) Kejin Zhang et al.   GENE

MicroRNAs in cutaneous melanoma: Role as diagnostic and prognostic biomarkers

(2018) Casey L. Ross et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Long Noncoding RNA MEG3 Inhibits Cell Proliferation and Metastasis in Chronic Myeloid Leukemia via Targeting miR-184

(2018) Jingdong Li et al.   ONCOLOGY RESEARCH

Long noncoding RNAs act as regulators of autophagy in cancer

(2018) Ting Sun   PHARMACOLOGICAL RESEARCH

Roles of Long Noncoding RNAs in Recurrence and Metastasis of Radiotherapy-Resistant Cancer Stem Cells

(2017) Hsiang-Cheng Chi et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Continued Increase in Melanoma Incidence across all Socioeconomic Status Groups in California, 1998–2012

(2017) Christina A. Clarke et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Overexpression of long non-coding RNA MEG3 suppresses breast cancer cell proliferation, invasion, and angiogenesis through AKT pathway

(2017) Chen-yu Zhang et al.   TUMOR BIOLOGY

LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma

(2017) Jiangfeng Hu et al.   Oncotarget

Potential applications of MEG3 in cancer diagnosis and prognosis

(2017) Yuqing He et al.   Oncotarget

Using RNA sequencing to identify putative competing endogenous RNAs (ceRNAs) potentially regulating fat metabolism in bovine liver

(2017) Ruobing Liang et al.   Scientific Reports

Strategies to use microRNAs as therapeutic targets

(2016) Jan Krützfeldt   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD

(2016) Mingxia Zhu et al.   Molecular Medicine Reports

miR-186 suppressed CYLD expression and promoted cell proliferation in human melanoma

(2016) Haijiang Qiu et al.   Oncology Letters

Overexpression of miR-499-5p inhibits non-small cell lung cancer proliferation and metastasis by targeting VAV3

(2016) Ming Li et al.   Scientific Reports

MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma

(2015) Fang Ni et al.   CANCER LETTERS

CYLD deletion triggers nuclear factor-κB-signaling and increases cell death resistance in murine hepatocytes

(2014) Toni Urbanik   WORLD JOURNAL OF GASTROENTEROLOGY

MicroRNAs and other non-coding RNAs as targets for anticancer drug development

(2013) Hui Ling et al.   NATURE REVIEWS DRUG DISCOVERY

CYLD Inhibits Melanoma Growth and Progression through Suppression of the JNK/AP-1 and β1-Integrin Signaling Pathways

(2012) Hengning Ke et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

CYLD negatively regulates transforming growth factor-β-signalling via deubiquitinating Akt

(2012) Jae Hyang Lim et al.   Nature Communications

microRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4

(2011) Xiangqiang Liu et al.   CARCINOGENESIS

Loss of the Tumor Suppressor CYLD Enhances Wnt/β-Catenin Signaling through K63-Linked Ubiquitination of Dvl

(2010) Daniele V.F. Tauriello et al.   MOLECULAR CELL